September 18, 2023

Intensity-Modulated Radiation Therapy Best for Locally Advanced NSCLC

Intensity-modulated radiation therapy spares more normal tissue than 3D-conformal radiotherapy Intensity-modulated radiation therapy (IMRT) shows benefits over 3D-conformal (3D-CRT) radiotherapy for patients with locally advanced non-small cell lung cancer (NSCLC), according to a study presented at the International Association for the Study of Lung Cancer 2023 World Conference on Lung Cancer, held from Sept. 9...

Tobacco, Cannabis Use Tied to High Rates of Self-Reported Mental Health Issues

Daily use of cigarettes, e-cigarettes, and cannabis associated with both anxiety and depression Use of tobacco and/or cannabis, particularly co-use of both substances, is associated with poor mental health, according to a study published online Sept. 13 in PLOS ONE. Nhung Nguyen, Ph.D., from the University of California, San Francisco, and colleagues used data from the...

Diet, Exercise Intervention May Aid Chemotherapy Outcomes in Breast Cancer

Staff Writer: Andre McGowan Although relative dose intensity similar, pathologic complete response higher with intervention A home-based diet and exercise intervention could improve outcomes for women undergoing chemotherapy for breast cancer, according to a study published online Sept. 1 in the Journal of Clinical Oncology. Tara Sanft, M.D., from Yale University in New Haven, Connecticut, and...

Concurrent Use of Fentanyl, Stimulants Common in Overdoses

Proportion of stimulant involvement in fentanyl-involved overdose deaths increased in almost every state from 2015 to 2021 By 2021, stimulants were the most common drug class found in fentanyl-involved overdoses, according to a study published online Sept. 13 in Addiction. Joseph Friedman, Ph.D., and Chelsea L. Shover, Ph.D., from the University of California in Los Angeles,...

Top 7 Latest Advances in Multiple Myeloma

The field of multiple myeloma (MM) treatment has seen significant advancements in recent years, which have improved median survival rates for patients from 3 years two decades ago to around 10 years now. One of the most notable advancements in the treatment of MM is the introduction of immune-based therapies, specifically anti-CD38 monoclonal antibodies. These...

Stay informed on the latest health disparities research, cultural sensitivity education, and how you can help improve patient outcomes.
This field is for validation purposes and should be left unchanged.